Pregled bibliografske jedinice broj: 101256
Oral Estramustine therapy in serum Chromogranin A-positive Stage D3 prostate cancer patients.
Oral Estramustine therapy in serum Chromogranin A-positive Stage D3 prostate cancer patients. // Anticancer Research, 21 (2001), 1475-1480 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 101256 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Oral Estramustine therapy in serum Chromogranin A-positive Stage D3 prostate cancer patients.
Autori
Ahel, Zaky ; Kovačić, Ksenija ; Kraljić, Ivo ; Tarle, Marko.
Izvornik
Anticancer Research (0250-7005) 21
(2001);
1475-1480
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
prostate cancer; estramustine; chromogranin A
Sažetak
Forty four pts with stage D3 prostate cancer were treated with estramustine during 15 months period. Monitoring included CgA value, TPSA level and bone scan data. Average response period evaluated by CgA decrease and inprovenent in bone scan data was 8.7 months.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Index Medicus
